The researchers at the Royal College of Surgeons Ireland recently received €1.3 million from Wellcome Trust to support the development of the blood-based test.
Vermillion Eyes $17M in Public Offering of Stock
The firm expect to raise gross proceeds of $15 million, or $17.25 million if the offering's underwriter exercises its option to purchase additional shares.
Sera Prognostics Gets NY State Approval to Test for Preterm Birth
With the approval Sera is permitted to provide lab testing services ordered by a medical professional for use by pregnant women in all US states.
Proteomics International, Janssen Collaborating to Evaluate PromarkerD Kidney Disease Test
The companies will evaluate the performance of Proteomics International's PromarkerD test for predicting decline in kidney function and drug response.
The company is confident about bringing the test to market despite potential future competition and views it as an easy fit for its existing sales channels.